Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Read the Original
This page is a summary of: Corrigendum to “Novel highly efficient intrabody mediates complete inhibition of cell surface expression of the human vascular endothelial growth factor receptor-2 (VEGFR-2/KDR)” [Journal of Immunological Methods 300 (2005) 146–159], Journal of Immunological Methods, August 2005, Elsevier, DOI: 10.1016/j.jim.2005.08.003.
You can read the full text:
The following have contributed to this page